They are now broadly available in the UK, are used both for those who are every vulnerable and in over-50s studies. We have 4.25 million doses.
Antiviral medicines such as molnupiravir are also available through a national study, run by Oxford University.
The study is open to people living anywhere in the UK who:
- have received a positive COVID-19 PCR test
- have COVID-19 symptoms that started within the last 5 days
- are aged 50 and over, or are aged 19 to 49 years with an underlying medical condition that can increase the risk of developing severe COVID-19
If you take part in the study you may be randomly selected to:
- receive a course of antiviral medicines
- not receive the medicine
This research study is needed to see if there are any differences in the health of those who take molnupiravir compared to those who do not.
You yourself has questioned Mercks lastest and greatest. Would you take it?